Prior to several years in private consulting, Dr. Chris Teleha had been at Janssen R&D, part of the family of companies of Johnson & Johnson (J&J) since 2003 and became Scientific Director R&D in 2012. There he contributed to a wide range of research projects, including process development for important candidates in the pipeline. Dr Teleha was also an Associate Director at DuPont Pharmaceuticals, later acquired by Bristol-Myers Squibb, where he became a Director. Chris’ very recent retirement provided the ITTC with an opportunity to capitalise on his substantial experience in the international pharmaceutical industry and his assistance with ITTC development opportunities and partnerships with pharma, biotech and translational research organisations.